Covid-19 Impact on Immunoassay in the Healthcare Industry: Diagnostics, Immunoassays, Vaccines, Telehealth and Other Areas The global immunoassay market is growing pervasively. The market growth attributes to the increase in biological studies in R&D for the detection of biomolecules like glycans, proteins, and small biological and non-biological molecules of various diseases. Also, immunoassays are primarily used for rapid and sensitive diagnostics of various chronic diseases such as cancer, autoimmune diseases, infectious diseases like HIV, neurological disorders such as Alzheimer’s and Parkinson’s diseases. The coronavirus disease epidemic stresses the need for a simple and reliable test tool to identify and diagnose the target virus. Improved urgent need for the successful production of drugs and vaccines to curb COVID 19 spread is the advancement of the accelerated process, including immunoassay.
Figure1: Number of Laboratory Confirmed COVID-19 Cases
Request a report sample to gain more market insights at: https://www.databridgemarketresearch.com/covid-19-resources/covid-19-impacton-immunoassay-in-the-healthcare-industry
Scope of Immunoassay Market: The report offers key drivers that propel the growth in the global Immunoassay Market. These insights help market players in devising strategies to gain market presence. The research also outlined the restraints of the market. Insights on opportunities are mentioned to assist market players in taking further steps by determining the potential in untapped regions. Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Immunoassay Market which would mention How the Covid-19 is Affecting the Disposable Incontinence Products (DIPs) Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Covid-19 Impact on Key Regions and Proposal for Disposable Incontinence Products (DIPs) Players to fight Covid-19 Impact. Immunoassay Market report also covers all the regions and countries of the world, which shows a regional development status. Regional Segmentation:
Europe (Germany, U.K., France, Italy, Russia, Spain, etc.) South America (Brazil, Argentina, etc.) Middle East & Africa (Saudi Arabia, South Africa, etc.)
Supply Chain Impacts: Because of the persistent outbreak of COVID-19, multiple restrictions have been imposed by government bodies from many countries that include, among others, ban across the country's borders. Such limitations led to a shortage of immunoassay kits in the market. Although such lockdown Indian government has allowed the importation of some kits used to detect coronavirus immunoassay. Abbott Healthcare and Roche Diagnostics obtained clearance for the import of immunoassay kits according to the study published in May 2020. This approval requires the importation of immunoassay kits with chemiluminescent effect. This measure by the Indian government helped hold a continuous supply chain in the midst of COVID-19. This signifies that several strategic initiatives by different manufacturers in order to fight against novel coronavirus, fuel up the market growth.
Presence of large number of Immunoassay kits are helping the doctors and scientist to get an optimal solution as per their need, which again led to increasing growth of the market
TABLE 1. DIFFERENT TYPES OF IMMUNOLOGICAL TESTS USED FOR DETECTION OF VIRAL ANTIBODIES FORMED AGAINST SARS- CoV-2 VIRUS
Test Name
Test Type
Manufacturer
m2000 SARS-CoV-2 assay
chemiluminescent microparticle immunoassay
Abbott Laboratory
COVID-19 IgG/IgM LF
lateral flow immunoassay
Advagen Biotech
serum/plasma/who blood
COVID-19 IgM/IgG rapid test
lateral flow immunoassay
BioMedomics
serum/plasma/who blood
One-Step COVID-2019 test
lateral flow immunoassay
Celer Biotechnologia
serum/plasma/who blood
qSARS-CoV-2 IgG/IgM rapid test
lateral flow immunoassay
Cellex Inc.
serum/plasma/who blood
DEIASL019/020 SARS-CoV-2 ELISA IgG ELISA kit
Creative Diagnostics
serum/plasma
OnSite COVID-19 rapid test
CTK Biotech Inc. (USA)
serum/plasma/who blood
IgG/IgM lateral flow immunoassay
Sample Sources
Core serum/plasma/who blood
Particular sections address the most important market changes: Molecular Diagnostics: It's important to note that the entire molecular testing concept originated in the midst of a crisis, at that time of the AIDS crisis, and has since been brought to bear on a number of emerging and mature infectious disease categories. COVID-19 has seen the molecular in vitro diagnostics (IVD) industry bring out its best efforts in terms of fast test RTPCR tests for their systems, point of care solutions, syndromic tests, high throughput systems and surge production on badly needed kits.
Immunoassays: Never have immunoassays been of such worldwide attention, as antibody tests are greatly sought. With this, come concerns about accuracy levels on broad populations and greater knowledge about development times. There are now immunoassays in development. We track these efforts and provide commentary on the role of these tests in a threat so far dominated by molecular diagnostics. Vaccines: The analyst look at the vaccines in development and the struggles with vaccine discovery and manufacturing in other pandemics. Companies developing vaccines are featured. Other Traditional IVDs: With many hospitals shut down across the globe, what is the impact and expected future of standard in vitro diagnostic testing? - from company statements made both publicly and directly to the analyst. Remote Patient Monitoring: Already a healthcare trend that was catching on but perhaps struggling to convince payors of its critical necessity, remote patient monitoring, and telehealth transformed overnight with social distancing policies and relaxed HIPAA rules. But will market players be crowded out by traditional phone and web video companies?
Conclusion: The COVID 19 pandemic has led to an urgent need for coronavirus identification to advance the disease stage and create a novel vaccine that can be used with immunoassay kits to easily detect coronavirus-formed antibodies. This led to increased demand for immunoassay kits and boosted immunoassay market growth.
Browse For More: 
Covid-19 Impact on In-Vitro Diagnostics in the Healthcare Industry

COVID-19: Effect of Convalescent Plasma Therapy in Healthcare Industry